Here's Shares Agios Pharmaceuticals: 2026 Outlook and Rally
Biotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Identify immediate actions when faced with unexpected financial situations. Prioritize essentials, adjust spending, and seek timely support if needed.
21,236 articlesBiotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Investors speculate on Kevin Warsh becoming Fed chair, a move that could alter rate paths, liquidity and the long-run...
Susquehanna lifts Cloudflare to a $200 price target as the AI-first reset takes shape. The stock sits near $196 after...
In healthcare robotics, durable moats matter as much as dazzling tech. This article breaks down why intuitive surgica...
TONX reported healthy momentum in Q1 2026, but the real story lies in its growth engine. This article breaks down th...
The Department of Homeland Security is requesting $7.5 million to develop wearable facial-recognition glasses for ICE...
A cooler April jobs report challenges early COLA forecasts for Social Security. Investors weigh retirement income ris...
Q1 2026 earnings transcripts reveal more than quarterly numbers. Explore how guidance, margin trends, and management ...
Netflix surprised investors by raising its 2026 free cash flow guidance, spotlighting growth in ads and international...
Archer Aviation trades under $7 as it pursues a future of urban air taxis. This deep-dive breaks down milestones, ris...
Amazon blends a sprawling logistics network with a fast-growing AI infrastructure business, signaling a rare asset-he...
A sharp move in bicara stock 50% has spotlighted a bold biotech bet that now accounts for nearly a third of one inves...